LKQ Corporation Initiates Sale Process for Specialty Segment Continues Multi-Year Portfolio Simplification Strategy GlobeNewswire December 04, 2025 ANTIOCH, Tenn., Dec. 04, 2025 (GLOBE NEWSWIRE) — LKQ Corporation (Nasdaq: LKQ) today announced that it has commenced a process to explore the potential sale of its Specialty segment. “Our Specialty segment is a leading distributor of automotive, […]
Winnebago Industries to Announce First Quarter Fiscal 2026 Financial Results on December 19, 2025 GlobeNewswire December 04, 2025 EDEN PRAIRIE, Minn., Dec. 04, 2025 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor recreation product manufacturer, plans to issue its first quarter fiscal 2026 financial results before the opening of the New York
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement GlobeNewswire December 04, 2025 SOUTH SAN FRANCISCO, Calif. and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI) and Royalty Pharma plc (Nasdaq: RPRX) today announced a $275 million synthetic royalty funding agreement based on future net sales of tividenofusp
REPEAT — QGold Strengthens Board of Directors with Appointment of Jamsheed Mehta, former Vice-Chair at BMO Capital Markets GlobeNewswire December 04, 2025 TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Borse Frankfurt: QX9G) (“QGold” or the “Company“) is pleased to announce the appointment of Jamsheed Mehta to its Board
Microbix Announces Initiation of Normal Course Issuer Bid For Repurchase of up to 5% of its outstanding shares over 12 months GlobeNewswire December 04, 2025 MISSISSAUGA, Ontario, Dec. 04, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the initiation
Atavistik Bio to Present Discovery of JAK2 V617F Mutant-Selective Allosteric Inhibitors for the Treatment of Myeloproliferative Neoplasms (MPNs) at ASH 2025 GlobeNewswire December 04, 2025 Atavistik Bio to present the discovery and characterization of novel allosteric JAK2 V617F selective inhibitors that suppress mutant-dependent signaling and proliferation while sparing wild-type JAK2 Atavistik Bio's JAK2 V617F mutant-selective
2025 Cannabis Holiday Gift Guide Highlights Canada's Most Popular Cannabis Products for the Holiday Season GlobeNewswire December 04, 2025 TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today released
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 04, 2025 RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted four newly-hired employees stock options to purchase an aggregate of 57,100 shares, and restricted stock
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress GlobeNewswire December 04, 2025 New data showcase the versatility and anti-tumor activity of the CAPTN-3 platform and its unique multi-arm design in treatment-resistant cancers REHOVOT, Israel, Dec. 04, 2025 (GLOBE
New Crypto Mutuum Finance (MUTM) Reports Phase 2 Roadmap Progress as V1 Testnet Approaches Q4 Release GlobeNewswire December 04, 2025 DUBAI, United Arab Emirates, Dec. 04, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project in the DeFi sector, has released an update on its current development progress as the project moves through